tiprankstipranks
Merus gets FDA approval of BIZENGRI in NRG1+ Pancreatic Adenocarcinoma, NSCLC
PremiumThe FlyMerus gets FDA approval of BIZENGRI in NRG1+ Pancreatic Adenocarcinoma, NSCLC
1M ago
Merus’ zenocutuzumab-zbco granted accelerated approval by FDA
Premium
The Fly
Merus’ zenocutuzumab-zbco granted accelerated approval by FDA
1M ago
Merus price target lowered to $109 from $111 at Guggenheim
Premium
The Fly
Merus price target lowered to $109 from $111 at Guggenheim
2M ago
Merus reports Q3 EPS ($1.46), consensus (88c)
PremiumThe FlyMerus reports Q3 EPS ($1.46), consensus (88c)
3M ago
Merus sees cash runway into 2028
Premium
The Fly
Merus sees cash runway into 2028
3M ago
Merus NV (MRUS) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Merus NV (MRUS) Q3 Earnings Cheat Sheet
3M ago
Merus price target raised to $111 from $93 at Guggenheim
PremiumThe FlyMerus price target raised to $111 from $93 at Guggenheim
4M ago
Merus announces first patient dosed in LiGeR-HN1 Phase 3 trial
Premium
The Fly
Merus announces first patient dosed in LiGeR-HN1 Phase 3 trial
4M ago
Merus announces abstract accepted for presentation at ESMO Asia Congress 2024
Premium
The Fly
Merus announces abstract accepted for presentation at ESMO Asia Congress 2024
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100